Lineage Cell Therapeutics
LCTX
#8509
Rank
โ‚ฌ0.22 B
Marketcap
0,91ย โ‚ฌ
Share price
-3.74%
Change (1 day)
-7.53%
Change (1 year)

Revenue for Lineage Cell Therapeutics (LCTX)

Revenue in 2026 (TTM): โ‚ฌ12.59 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ12.99 Million. In 2025 the company made a revenue of โ‚ฌ12.39 Million an increase over the revenue in the year 2024 that were of โ‚ฌ9.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lineage Cell Therapeutics from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ12.59 M1.67%
2025 โ‚ฌ12.39 M35.74%
2024 โ‚ฌ9.12 M12.81%
2023 โ‚ฌ8.09 M-40.97%
2022 โ‚ฌ13.7 M298.44%
2021 โ‚ฌ3.44 M447.4%
2020 โ‚ฌ0.62 M-52.37%
2019 โ‚ฌ1.31 M6.59%
2018 โ‚ฌ1.23 M-17.12%
2017 โ‚ฌ1.49 M-29.87%
2016 โ‚ฌ2.12 M-8.04%
2015 โ‚ฌ2.31 M44.79%
2014 โ‚ฌ1.59 M-22.8%
2013 โ‚ฌ2.07 M1470.12%
2012 โ‚ฌ0.13 M-96.1%
2011 โ‚ฌ3.38 M22.31%
2010 โ‚ฌ2.76 M106.04%
2009 โ‚ฌ1.34 M24.92%
2008 โ‚ฌ1.07 M50.14%
2007 โ‚ฌ0.71 M-18.64%
2006 โ‚ฌ0.88 M15.5%
2005 โ‚ฌ0.76 M50.25%
2004 โ‚ฌ0.5 M14.82%
2003 โ‚ฌ0.44 M19.37%
2002 โ‚ฌ0.37 M115.23%
2001 โ‚ฌ0.17 M146.99%
2000 โ‚ฌ0.06 M-93.24%
1999 โ‚ฌ1.03 M
1997 โ‚ฌ0.5 M100%
1996 โ‚ฌ0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA